Cargando…

Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study

BACKGROUND: Patterns of healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder (GAD) have not been well characterized. METHODS: Using a large US health insurance database, we identified all patients with evidence of GAD (ICD-9-CM diagnosis code 300.02...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berger, Ariel, Edelsberg, John, Bollu, Vamsi, Alvir, Jose Ma J, Dugar, Ashish, Joshi, Ashish V, Oster, Gerry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266199/ https://www.ncbi.nlm.nih.gov/pubmed/22151689 http://dx.doi.org/10.1186/1471-244X-11-193

Ejemplares similares

Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study
por: Berger, Ariel, et al.
Publicado: (2012)

Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study
por: Berger, Ariel, et al.
Publicado: (2012)

Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study
por: Berger, Ariel, et al.
Publicado: (2012)

Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder
por: Berger, Ariel, et al.
Publicado: (2009)

Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: A retrospective cohort study
por: Berger, Ariel, et al.
Publicado: (2012)

Use of Sildenafil in Pulmonary Arterial Hypertension: Findings from a U.S. Healthcare Claims Database
por: Berger, Ariel, et al.
Publicado: (2014)

Characteristics and healthcare costs of patients with fibromyalgia syndrome
por: Berger, A, et al.
Publicado: (2007)

Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States
por: Nag, Arpita, et al.
Publicado: (2020)

Resource utilization and costs before and after total joint arthroplasty
por: Bozic, Kevin J, et al.
Publicado: (2012)

FRAILTY INDEX AT THE BEGINNING OF ELDERHOOD AND HEALTHCARE COSTS AND UTILIZATION OVER 10 YEARS
por: Jang, Jieun, et al.
Publicado: (2022)

Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective
por: Vera-Llonch, Montserrat, et al.
Publicado: (2009)

Smoking Cessation Pharmacotherapy Utilization and Costs to a Medicaid Managed Care Plan
por: Corelli, Robin L., et al.
Publicado: (2021)

Pharmacotherapy for anxiety disorders in children and adolescents
por: Kodish, Ian, et al.
Publicado: (2011)

Pharmacotherapy for mood and anxiety disorders in older people with intellectual disability in comparison with the general population
por: Axmon, Anna, et al.
Publicado: (2019)

197. Healthcare Resource Utilization and Costs Associated with Inappropriate and Suboptimal Prescribing of Antibiotics for Uncomplicated Urinary Tract Infection in the United States
por: Moon, Rena, et al.
Publicado: (2021)

Healthcare costs in patients with metastatic lung cancer receiving chemotherapy
por: Vera-Llonch, Montserrat, et al.
Publicado: (2011)

Pharmacotherapy of anxiety disorders: a critical review
por: Koen, Nastassja, et al.
Publicado: (2011)

Editorial: Pharmacotherapy of Anxiety Disorders: Promises and Pitfalls
por: Garakani, Amir, et al.
Publicado: (2021)

Pharmacotherapy for Depression and Anxiety in the Primary Care Setting
por: Parish, Abby Luck, et al.
Publicado: (2023)

Epidemiology, survival, and costs of localized gastrointestinal stromal tumors
por: Rubin, Jaime L, et al.
Publicado: (2011)

Cost-Effectiveness of Pharmacotherapy to Reduce Obesity
por: Veerman, J. Lennert, et al.
Publicado: (2011)

Mental floss: “Many careers end in success… A few begin with it.”
por: Nichani, Ashish Sham
Publicado: (2011)

Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
por: Garakani, Amir, et al.
Publicado: (2020)

Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
por: Garakani, Amir, et al.
Publicado: (2021)

Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality
por: Vera-Llonch, Montserrat, et al.
Publicado: (2011)

Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents
por: Lim, Francesca, et al.
Publicado: (2023)

Cost-effectiveness of psychotherapies and pharmacotherapies for mental disorders
por: McCrone, P.
Publicado: (2023)

Trends in US Hospital Admissions for Skin and Soft Tissue Infections
por: Edelsberg, John, et al.
Publicado: (2009)

Compliance with Pharmacotherapy and Direct Healthcare Costs in Patients with Parkinson’s Disease: A Retrospective Claims Database Analysis
por: Richy, Florent F., et al.
Publicado: (2013)

Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine
por: Stein, Dan J.
Publicado: (2021)

Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management
por: Tsoi, Bernice, et al.
Publicado: (2015)

Pharmacology and Pharmacotherapy
por: Berger, Dietmar P., et al.
Publicado: (2008)

The cost‐effectiveness of pharmacotherapy and lifestyle intervention in the treatment of obesity
por: Lee, Minyi, et al.
Publicado: (2019)

Cost-Effectiveness of Adult Universal Hepatitis B Vaccination
por: Oster, Gerry, et al.
Publicado: (2022)

Healthcare utilization and costs associated with gastroparesis
por: Wadhwa, Vaibhav, et al.
Publicado: (2017)

Healthcare utilization and costs associated with cholangiocarcinoma
por: Wadhwa, Vaibhav, et al.
Publicado: (2017)

A cost-utility analysis of pregabalin versus venlafaxine XR in the treatment of generalized anxiety disorder in Portugal
por: Silva Miguel, Luís, et al.
Publicado: (2013)

Getting started with Spring Framework: a hands-on guide to begin developing applications using Spring Framework
por: Sharma, J, et al.
Publicado: (2016)

Association of opioid use disorder with healthcare utilization and cost in a public health system
por: Miron, Oren, et al.
Publicado: (2022)

Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes
por: Kaul, Subuhi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eettrvhf26upoldq15ons406jm